Jennifer Lynne Fox - 11 Nov 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Ext Aff, GC, Corp Sec
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
11 Nov 2022
Net transactions value
-$6,240
Form type
4
Filing time
15 Nov 2022, 15:13:50 UTC
Previous filing
03 Mar 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $6,240 -416 -1.3% $15.00 32,211 11 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock of Emergent BioSolutions Inc withheld to pay tax liability on shares of restricted stock awarded pursuant to Rule 16b-3(d), which vested on November 11, 2022.